Screener
Relmada Therapeutics, Inc. RLMD Invested capital
Discontinued — last reported Q2 '23
Invested capital at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed November 7, 2024. Open the filing →
- Filed
- Nov 7, 2024
- Fiscal quarter
- Q3 FY2024
- Calendar quarter
- Q3 2024
- Accession
- 0001213900-24-095398
FAQ
- What is Relmada Therapeutics, Inc.'s invested capital?
- Relmada Therapeutics, Inc. (RLMD) reported invested capital of $200.93M in Q2 2023.
- How has Relmada Therapeutics, Inc.'s invested capital changed year-over-year?
- Relmada Therapeutics, Inc.'s invested capital decreased by 39.9% year-over-year, from $334.28M to $200.93M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Relmada Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude